Evidence map›Paper›PMID 34977256›Full record

ArticleJournal of immunology research2021

Polymorphisms CYP2R1 rs10766197 and CYP27B1 rs10877012 in Multiple Sclerosis: A Case-Control Study.

A Martinez-Hernandez, E E Perez-Guerrero, M A Macias-Islas, C A Nava-Valdivia, A Villagomez-Vega, B Contreras-Haro, Y E Garcia-Ortega, Y Esparza-Guerrero, S G Gallardo-Moya, J I Gamez-Nava and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Association of Vitamin D Intake,Medical sciences (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Association of theGenes · 2023
    Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

A Martinez-HernandezPrograma de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0003-2206-6054
E E Perez-GuerreroInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.ORCID https://orcid.org/0000-0002-0007-1824
M A Macias-IslasDepartamento de Neurociencias, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.ORCID https://orcid.org/0000-0002-5613-6682
C A Nava-ValdiviaDepartamento de Microbiología Y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.ORCID https://orcid.org/0000-0003-3562-7033
A Villagomez-VegaDepartamento de Ciencias Biomédicas, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá, Mexico.ORCID https://orcid.org/0000-0002-8261-7893
B Contreras-HaroDepartamento de Ciencias Biomédicas, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá, Mexico.ORCID https://orcid.org/0000-0002-8443-3481
Y E Garcia-OrtegaHospital de Especialidades, Centro Médico Nacional de Occidente, Guadalajara, Jalisco, Mexico.ORCID https://orcid.org/0000-0002-2401-3741
Y Esparza-GuerreroPrograma de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0001-6871-9052
S G Gallardo-MoyaPrograma de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0002-6831-8950
J I Gamez-NavaPrograma de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0003-0001-3787
L Gonzalez-LopezPrograma de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0002-6517-6344
E Oliva-FloresPrograma de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.
N A Rodriguez-JimenezInstituto de Terapéutica Experimental Y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.ORCID https://orcid.org/0000-0001-7643-6298
F Cortes-EnriquezInstituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico.ORCID https://orcid.org/0000-0003-4546-2850
A M Saldaña-CruzInstituto de Terapéutica Experimental Y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.ORCID https://orcid.org/0000-0003-2272-9612
Universidad de Guadalajara · MXHospital de Especialidades · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) is a chronic autoimmune inflammatory disease. Low vitamin D levels have been reported to be a risk factor for MS, and genetic variances could be implicated. The aim of this study was to evaluate the association of MS with rs10766197 polymorphism of

resultsSerum 25(OH) vitamin D levels were lower in MS patients than in controls (

conclusionLower serum 25(OH) vitamin D levels were observed in MS patients than in controls, although these levels were not associated with disease progression. Carriers of GA + AA genotypes of

Indexed as

AllelesGenetic Predisposition to DiseasePolymorphism, Single Nucleotide25-Hydroxyvitamin D3 1-alpha-HydroxylaseAdultAgedAged, 80 and overBiomarkersCase-Control StudiesCholestanetriol 26-MonooxygenaseCytochrome P450 Family 2FemaleGenetic Association StudiesGenotypeHumansMale25-hydroxyvitamin D25-Hydroxyvitamin D3 1-alpha-HydroxylaseBiomarkersCholestanetriol 26-MonooxygenaseCYP27B1 protein, humanCYP2R1 protein, humanCytochrome P450 Family 2Vitamin D

Identifiers

PMID34977256
PMCPMC8718303
OpenAlexW4200032585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.